BTMD - Company ID 0001819253
The table below shows biote Corp.'s income statement line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $192.22M | $197.19M | $185.36M | $164.96M | $139.40M |
| Cost of revenue | - | - | - | - | - |
| Gross profit | - | - | - | - | - |
| R&D | - | - | - | - | - |
| SG&A | $101.81M | $107.45M | $98.83M | $171.10M | $49.05M |
biote Corp. reported annual revenue of $192.22M for fiscal year 2025. That is down 2.5% from $197.19M in fiscal 2024. Over the 5 fiscal years shown, annual revenue grew from $139.40M (FY 2021) to $192.22M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Operating income |
| $35.55M |
| $31.61M |
| $28.66M |
| -$60.72M |
| $34.56M |
| Income tax | $5.99M | $970.00K | $2.68M | $388.00K | $286.00K |
| Net income | $27.05M | $3.16M | $3.32M | -$969.00K | $11.11M |
| EPS (diluted) | $0.74 | $0.09 | $0.13 | -$0.12 | - |